Life Etc: In conversation with Bira 91's founder and CEO Ankur Jain-March 2024-www.financetom.com

Life Etc: In conversation with Bira 91's founder and CEO Ankur Jain

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Life Etc: In conversation with Bira 91's founder and CEO Ankur Jain

Dec 5, 2019 2:01 PM

On CNBC-TV18's special show Life Etc, Anuradha Sengupta spoke to Bira 91's founder and chief executive officer Ankur Jain to find how he has disrupted a very conventional traditional business.

First Published:Dec 5, 2019 11:01 PM IST

Previous page： Medexus Pharmaceuticals to Launch Normal Course Issuer Bid Next page： Lucid launches cheaper variant of Gravity electric SUV to broaden appeal

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Medexus Pharmaceuticals to Launch Normal Course Issuer Bid

Nov 20, 2025

01:58 PM EST, 11/20/2025 (MT Newswires) -- Medexus Pharmaceuticals ( MEDXF ) on Thursday said it received exchange approvals to launch a normal course issuer bid (NCIB).. The company may buy back for cancellation up to 2.98-million shares, about 10% of the public float. As of Nov. 12, the company had 32.4-million shares outstanding and a public float of 29.8-million...

Lucid launches cheaper variant of Gravity electric SUV to broaden appeal

Nov 20, 2025

Nov 20 (Reuters) - Lucid Group ( LCID ) on Thursday launched a cheaper variant of its Gravity SUV with a starting price of $79,900, as the luxury electric-vehicle maker seeks to reach a broader audience amid slowing EV sales in United States. The Gravity Touring, offers up to 337 miles of range and seats seven, joining the higher-priced Grand...

Cemtrex to Acquire Invocon for $7.06 Million

Nov 20, 2025

01:59 PM EST, 11/20/2025 (MT Newswires) -- Cemtrex ( CETX ) said Thursday it has agreed to acquire Invocon, a Texas-based aerospace and defense engineering firm, for $7.06 million. The deal, which is subject to customary closing conditions, is expected to close on or around Jan. 1, 2026, the company said. After the acquisition closes, Cemtrex ( CETX ) plans...

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat

Nov 20, 2025

Vanda Pharmaceuticals Inc. ( VNDA ) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Novo Nordisk A/S ( NVO ) Wegovy. • Get the market research on VNDA stock here. The trial studied 116 healthy overweight or obese adults. The study saw 29.3% of tradipitant-treated participants (17/58)...